Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Stempel

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Allergy and Asthma Proceedings|June 11, 2010
Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapyMay Hagiwara, Thomas E Delea, Richard H Stanford, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2020
The Adoption and Implementation of Digital Health Care in the Post-COVID-19 EraGiselle S Mosnaim, Hilary Stempel, David Van Sickle, et al.
BMJ Open|April 25, 2013
Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysisRachael L Disantostefano, Hao Li, David B Rubin, et al.
Current Medical Research and Opinion|November 27, 2008
Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*Thomas E Delea, Richard H Stanford, May Hagiwara, et al.
Allergy and Asthma Proceedings|July 10, 2010
Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthmaThomas E Delea, May Hagiwara, David A Stempel, et al.
Clinical Therapeutics|April 15, 2008
Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthmaThomas E Delea, May Hagiwara, Richard H Stanford, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|May 14, 2013
An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005-2011Rachael L DiSantostefano, Anne M Yeakey, Ibrahim Raphiou, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2005
Patterns of asthma control: a 3-year analysis of patient claimsDavid A Stempel, Trent P McLaughin, Richard H Stanford, et al.
Frontiers in Digital Health|October 29, 2021
Concurrent Improvement Observed in Patient-Reported Burden and Sensor-Collected Medication Use Among Patients Enrolled in a COPD Digital Health ProgramLeanne Kaye, Rahul Gondalia, Meredith A Barrett, et al.
Scientific Reports|December 22, 2021
The relationship between objective app engagement and medication adherence in asthma and COPD: a retrospective analysisLeanne Kaye, Rahul Gondalia, Alesha Thompson, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Allergy and Asthma Proceedings|June 11, 2010
Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapyMay Hagiwara, Thomas E Delea, Richard H Stanford, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2020
The Adoption and Implementation of Digital Health Care in the Post-COVID-19 EraGiselle S Mosnaim, Hilary Stempel, David Van Sickle, et al.
BMJ Open|April 25, 2013
Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysisRachael L Disantostefano, Hao Li, David B Rubin, et al.
Current Medical Research and Opinion|November 27, 2008
Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*Thomas E Delea, Richard H Stanford, May Hagiwara, et al.
Allergy and Asthma Proceedings|July 10, 2010
Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthmaThomas E Delea, May Hagiwara, David A Stempel, et al.
Clinical Therapeutics|April 15, 2008
Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthmaThomas E Delea, May Hagiwara, Richard H Stanford, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|May 14, 2013
An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005-2011Rachael L DiSantostefano, Anne M Yeakey, Ibrahim Raphiou, et al.
The Journal of Allergy and Clinical Immunology|May 4, 2005
Patterns of asthma control: a 3-year analysis of patient claimsDavid A Stempel, Trent P McLaughin, Richard H Stanford, et al.
Frontiers in Digital Health|October 29, 2021
Concurrent Improvement Observed in Patient-Reported Burden and Sensor-Collected Medication Use Among Patients Enrolled in a COPD Digital Health ProgramLeanne Kaye, Rahul Gondalia, Meredith A Barrett, et al.
Scientific Reports|December 22, 2021
The relationship between objective app engagement and medication adherence in asthma and COPD: a retrospective analysisLeanne Kaye, Rahul Gondalia, Alesha Thompson, et al.
Pageof 9